These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34705778)

  • 1. Factors Associated with the Development, Progression, and Outcome of Dupuytren Disease Treatment: A Systematic Review.
    Geoghegan L; Man J; Jain A; Price A; Gibbons E; Jerosch-Herold C; Sidey-Gibbons C; Rodrigues JN
    Plast Reconstr Surg; 2021 Nov; 148(5):753e-763e. PubMed ID: 34705778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and Direct Costs of Needle Aponeurotomy, Collagenase Injection, and Fasciectomy in the Treatment of Dupuytren Contracture.
    Leafblad ND; Wagner E; Wanderman NR; Anderson GR; Visscher SL; Maradit Kremers H; Larson DR; Rizzo M
    J Hand Surg Am; 2019 Nov; 44(11):919-927. PubMed ID: 31537401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgical treatment of Dupuytren contracture].
    Hahn P; Unglaub F
    Oper Orthop Traumatol; 2016 Feb; 28(1):2-3. PubMed ID: 26184721
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary intervention in Dupuytren's disease].
    Vesper US; Mehling IM; Arsalan-Werner A; Sauerbier M
    Orthopade; 2017 Apr; 46(4):336-341. PubMed ID: 28243691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Minimally Invasive Treatment of Dupuytren Disease.
    Hovius SER; Zhou C
    Hand Clin; 2018 Aug; 34(3):417-426. PubMed ID: 30012301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacies and limitations of fasciectomy and collagenase clostridium histolyticum in Dupuytren's contracture management: A meta-analysis.
    Cooper TB; Poonit K; Yao C; Jin Z; Zheng J; Yan H
    J Orthop Surg (Hong Kong); 2020; 28(2):2309499020921747. PubMed ID: 32484064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Recurrent Dupuytren Disease.
    Kaplan FTD; Crosby NE
    Hand Clin; 2018 Aug; 34(3):403-415. PubMed ID: 30012300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of Treatment for Dupuytren Disease.
    Eberlin KR; Mudgal CS
    Hand Clin; 2018 Aug; 34(3):387-394. PubMed ID: 30012298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dupuytren's disease: current treatment concepts].
    Unglaub F; Spies CK
    Orthopade; 2017 Apr; 46(4):297. PubMed ID: 28382393
    [No Abstract]   [Full Text] [Related]  

  • 10. Bringing It All Together: A Practical Approach to the Treatment of Dupuytren Disease.
    Haase SC; Chung KC
    Hand Clin; 2018 Aug; 34(3):427-436. PubMed ID: 30012302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Needle Fasciotomy Versus Collagenase Treatment for Dupuytren Contracture: A Randomized Controlled Trial with a Two-Year Follow-up.
    Strömberg J; Ibsen Sörensen A; Fridén J
    J Bone Joint Surg Am; 2018 Jul; 100(13):1079-1086. PubMed ID: 29975270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture.
    Räisänen MP; Karjalainen T; Göransson H; Reito A; Kautiainen H; Malmivaara A; Leppänen OV
    BMJ Open; 2018 Mar; 8(3):e019054. PubMed ID: 29599391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical Management of Dupuytren Disease: A Systematic Review and Network Meta-analyses.
    Nann S; Kovoor J; Fowler J; Kieu J; Gupta A; Hewitt J; Ovenden C; Edwards S; Bacchi S; Jacobsen JHW; Harries R; Maddern G
    Hand (N Y); 2024 Nov; 19(8):1283-1292. PubMed ID: 37246411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.
    Smeraglia F; Del Buono A; Maffulli N
    Br Med Bull; 2016 Jun; 118(1):149-58. PubMed ID: 27151958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Outcomes of Dupuytren Disease Treatment.
    Binhammer P
    Hand Clin; 2018 Aug; 34(3):377-386. PubMed ID: 30012297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' perspectives of collagenase injection or needle fasciotomy and rehabilitation for Dupuytren disease, including hand function and occupational performance.
    Winberg M; Turesson C
    Disabil Rehabil; 2023 Mar; 45(6):986-996. PubMed ID: 35261296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dupuytren disease--formal pathogenesis without contraction and a new surgery concept].
    Meinel A
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1292-4. PubMed ID: 9931862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of Dupuytren disease.
    Desai SS; Hentz VR
    J Hand Surg Am; 2011 May; 36(5):936-42. PubMed ID: 21527148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable Collagenase Versus Percutaneous Needle Fasciotomy for Dupuytren Contracture in Proximal Interphalangeal Joints: A Randomized Controlled Trial.
    Skov ST; Bisgaard T; Søndergaard P; Lange J
    J Hand Surg Am; 2017 May; 42(5):321-328.e3. PubMed ID: 28473158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data.
    Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Tursi JP; Cohen B; Kaufman GJ; Lindau T
    J Hand Surg Am; 2013 Jan; 38(1):12-22. PubMed ID: 23200951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.